231 related articles for article (PubMed ID: 31135066)
1. MicroRNA-326 suppresses iNOS expression and promotes autophagy of dopaminergic neurons through the JNK signaling by targeting XBP1 in a mouse model of Parkinson's disease.
Zhao XH; Wang YB; Yang J; Liu HQ; Wang LL
J Cell Biochem; 2019 Sep; 120(9):14995-15006. PubMed ID: 31135066
[TBL] [Abstract][Full Text] [Related]
2. Suppressed microRNA-96 inhibits iNOS expression and dopaminergic neuron apoptosis through inactivating the MAPK signaling pathway by targeting CACNG5 in mice with Parkinson's disease.
Dong Y; Han LL; Xu ZX
Mol Med; 2018 Nov; 24(1):61. PubMed ID: 30486773
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-326 Inhibits Apoptosis and Promotes Proliferation of Dopaminergic Neurons in Parkinson's Disease Through Suppression of KLK7-Mediated MAPK Signaling Pathway.
Zhang Y; Xu W; Nan S; Chang M; Fan J
J Mol Neurosci; 2019 Oct; 69(2):197-214. PubMed ID: 31270675
[TBL] [Abstract][Full Text] [Related]
4. Downregulated expression of microRNA-329 inhibits apoptosis of nigral dopaminergic neurons by regulating CDKN2D expression via the FoxO3a signaling pathway in rats with Parkinson's disease.
Liu YY; Zhang YN; Yang QS
J Cell Physiol; 2018 Nov; 233(11):8617-8629. PubMed ID: 29761857
[TBL] [Abstract][Full Text] [Related]
5. HOTAIR drives autophagy in midbrain dopaminergic neurons in the substantia nigra compacta in a mouse model of Parkinson's disease by elevating NPTX2
Lang Y; Li Y; Yu H; Lin L; Chen X; Wang S; Zhang H
Aging (Albany NY); 2020 May; 12(9):7660-7678. PubMed ID: 32396526
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of miR‑185 inhibits autophagy and apoptosis of dopaminergic neurons by regulating the AMPK/mTOR signaling pathway in Parkinson's disease.
Wen Z; Zhang J; Tang P; Tu N; Wang K; Wu G
Mol Med Rep; 2018 Jan; 17(1):131-137. PubMed ID: 29115479
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-181a Regulates Apoptosis and Autophagy Process in Parkinson's Disease by Inhibiting p38 Mitogen-Activated Protein Kinase (MAPK)/c-Jun N-Terminal Kinases (JNK) Signaling Pathways.
Liu Y; Song Y; Zhu X
Med Sci Monit; 2017 Apr; 23():1597-1606. PubMed ID: 28365714
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-124 regulates the expression of p62/p38 and promotes autophagy in the inflammatory pathogenesis of Parkinson's disease.
Yao L; Zhu Z; Wu J; Zhang Y; Zhang H; Sun X; Qian C; Wang B; Xie L; Zhang S; Lu G
FASEB J; 2019 Jul; 33(7):8648-8665. PubMed ID: 30995872
[TBL] [Abstract][Full Text] [Related]
9. microRNA-221 rescues the loss of dopaminergic neurons in a mouse model of Parkinson's disease.
Yao Y; Zhao Z; Zhang F; Miao N; Wang N; Xu X; Yang C
Brain Behav; 2023 Mar; 13(3):e2921. PubMed ID: 36795044
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
Kanagaraj N; Beiping H; Dheen ST; Tay SS
Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
[TBL] [Abstract][Full Text] [Related]
11. Suppression of microRNA-342-3p increases glutamate transporters and prevents dopaminergic neuron loss through activating the Wnt signaling pathway via p21-activated kinase 1 in mice with Parkinson's disease.
Wu DM; Wang S; Wen X; Han XR; Wang YJ; Shen M; Fan SH; Zhuang J; Zhang ZF; Shan Q; Li MQ; Hu B; Sun CH; Lu J; Chen GQ; Zheng YL
J Cell Physiol; 2019 Jun; 234(6):9033-9044. PubMed ID: 30362546
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of lncRNA BACE1-AS improves dopamine-dependent oxidative stress in rats with Parkinson's disease by upregulating microRNA-34b-5p and downregulating BACE1.
Li Y; Fang J; Zhou Z; Zhou Q; Sun S; Jin Z; Xi Z; Wei J
Cell Cycle; 2020 May; 19(10):1158-1171. PubMed ID: 32308102
[No Abstract] [Full Text] [Related]
13. miR-214-3p promotes the pathogenesis of Parkinson's disease by inhibiting autophagy.
Dong H; Yan J; Huang P; Wang X; Zhang R; Zhang C; Wang W; Qian W; Zhou J; Zhao Y; Gao J; Zhang M; Ma X; Wang Z; Yi C; Zhang J; Chen W
Biomed Pharmacother; 2024 Feb; 171():116123. PubMed ID: 38211424
[TBL] [Abstract][Full Text] [Related]
14. The Mechanism of SNHG8/Microrna-421-3p/Sorting Nexin 8 Axis on Dopaminergic Neurons in Substantia Nigra in a Mouse Model of Parkinson's Disease.
Zhou S; Zhou X; Jiang Z; Ma J; Li Y; Qian Z; Li H
Neurochem Res; 2023 Mar; 48(3):942-955. PubMed ID: 36401052
[TBL] [Abstract][Full Text] [Related]
15. [P38 MAPK signaling pathway regulates nuclear factor-κB and inducible nitric oxide synthase expressions in the substantia nigra in a mouse model of Parkinson's disease].
Wang Q; Zhang H; Liu M; Zhang Z; Wei Z; Sun N; Mao T; Zhang Y
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jul; 34(8):1176-80. PubMed ID: 25176090
[TBL] [Abstract][Full Text] [Related]
16. Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease.
Williams GP; Schonhoff AM; Jurkuvenaite A; Thome AD; Standaert DG; Harms AS
J Neuroinflammation; 2018 Aug; 15(1):244. PubMed ID: 30165873
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-185 activates PI3K/AKT signalling pathway to alleviate dopaminergic neuron damage via targeting IGF1 in Parkinson's disease.
Qin X; Zhang X; Li P; Wang M; Yan L; Pan P; Zhang H; Hong X; Liu M; Bao Z
J Drug Target; 2021 Sep; 29(8):875-883. PubMed ID: 33560148
[TBL] [Abstract][Full Text] [Related]
18. JNK inhibitor protects dopaminergic neurons by reducing COX-2 expression in the MPTP mouse model of subacute Parkinson's disease.
Wang Y; Zhang Y; Wei Z; Li H; Zhou H; Zhang Z; Zhang Z
J Neurol Sci; 2009 Oct; 285(1-2):172-7. PubMed ID: 19604516
[TBL] [Abstract][Full Text] [Related]
19. miR-425 deficiency promotes necroptosis and dopaminergic neurodegeneration in Parkinson's disease.
Hu YB; Zhang YF; Wang H; Ren RJ; Cui HL; Huang WY; Cheng Q; Chen HZ; Wang G
Cell Death Dis; 2019 Aug; 10(8):589. PubMed ID: 31383850
[TBL] [Abstract][Full Text] [Related]
20. Repulsive Guidance Molecule a (RGMa) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson's Disease.
Korecka JA; Moloney EB; Eggers R; Hobo B; Scheffer S; Ras-Verloop N; Pasterkamp RJ; Swaab DF; Smit AB; van Kesteren RE; Bossers K; Verhaagen J
J Neurosci; 2017 Sep; 37(39):9361-9379. PubMed ID: 28842419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
